THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,516,941 | -43.1% | 407,525 | -31.8% | 0.02% | -41.7% |
| Q2 2023 | $6,184,787 | -43.6% | 597,564 | -40.9% | 0.04% | -46.3% |
| Q1 2023 | $10,965,976 | -5.3% | 1,010,689 | -2.1% | 0.07% | -14.1% |
| Q4 2022 | $11,582,564 | +38.0% | 1,032,314 | +24.7% | 0.08% | +18.2% |
| Q3 2022 | $8,395,000 | +7.8% | 827,906 | -3.7% | 0.07% | +10.0% |
| Q2 2022 | $7,788,000 | -21.8% | 859,606 | -17.5% | 0.06% | -10.4% |
| Q1 2022 | $9,961,000 | -11.9% | 1,041,954 | +1.9% | 0.07% | -11.8% |
| Q4 2021 | $11,303,000 | +136.5% | 1,022,928 | +58.4% | 0.08% | +137.5% |
| Q3 2021 | $4,779,000 | -44.4% | 645,877 | +9.2% | 0.03% | -44.8% |
| Q2 2021 | $8,589,000 | -24.8% | 591,524 | +5.6% | 0.06% | -34.1% |
| Q1 2021 | $11,428,000 | +13.6% | 559,914 | -1.1% | 0.09% | 0.0% |
| Q4 2020 | $10,057,000 | +15.3% | 565,940 | -4.1% | 0.09% | -2.2% |
| Q3 2020 | $8,722,000 | -14.9% | 589,936 | +20.9% | 0.09% | -18.9% |
| Q2 2020 | $10,245,000 | +6.3% | 488,107 | +17.1% | 0.11% | -10.5% |
| Q1 2020 | $9,636,000 | -17.8% | 416,942 | -7.9% | 0.12% | +7.8% |
| Q4 2019 | $11,718,000 | +57.6% | 452,615 | +18.6% | 0.12% | +26.4% |
| Q3 2019 | $7,433,000 | +46.9% | 381,555 | +23.1% | 0.09% | +30.0% |
| Q2 2019 | $5,060,000 | -17.0% | 309,873 | +15.3% | 0.07% | -20.5% |
| Q1 2019 | $6,094,000 | +36.3% | 268,813 | +53.8% | 0.09% | +11.4% |
| Q4 2018 | $4,472,000 | -19.8% | 174,743 | +2.4% | 0.08% | 0.0% |
| Q3 2018 | $5,576,000 | +24.3% | 170,663 | -13.7% | 0.08% | +11.3% |
| Q2 2018 | $4,487,000 | +162.9% | 197,821 | +181.0% | 0.07% | +153.6% |
| Q1 2018 | $1,707,000 | +295.1% | 70,399 | +354.2% | 0.03% | +250.0% |
| Q4 2017 | $432,000 | -9.8% | 15,500 | -26.5% | 0.01% | -20.0% |
| Q2 2016 | $479,000 | – | 21,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |